04:52 PM EDT, 05/28/2024 (MT Newswires) -- Merus (MRUS) said Tuesday it launched a $300 million underwritten public offering of common shares, subject to market conditions.

The company expects to grant the underwriters a 30-day option to buy 15% of additional shares.

Proceeds together with existing cash, cash equivalents and marketable securities will be used to advance the company's clinical development programs, and for working capital and general corporate purposes, it said.

Price: 54.40, Change: -0.47, Percent Change: -0.86